that urine from patients with congestive heart failure showed an increase in sodiumretaining activity. This finding was the first suggestive evidence that a high blood level of aldosterone is present in heart failure and this result raised the question of the pathogenic importance of aldosterone in cardiac failure. In the present series of experiments, the role of aldosterone has been studied in experimental cardiac failure. Three important aspects of the problem are considered. To study these problemns we have used two chronic experimental preparations in dogs.
IN 1950, Deming and Luetscher1 reported that urine from patients with congestive heart failure showed an increase in sodiumretaining activity. This finding was the first suggestive evidence that a high blood level of aldosterone is present in heart failure and this result raised the question of the pathogenic importance of aldosterone in cardiac failure. In the present series of experiments, the role of aldosterone has been studied in experimental cardiac failure. Three important aspects of the problem are considered. First, does aldosterone promote the retention of salt and water and, if so, under what circumstances? Secondly, is hyperaldosteronenuia the result of both an increase in the rate of aldosterone production and a decreased rate of metabolism of the hormone? Thirdly, what stimulates the adrenal cortex to secrete large amounts of aldosterone in cardiac failure ? To study these problemns we have used two chronic experimental preparations in dogs.
The first of these is the dog with ascites produced by constricting the inferior vena cava in the thorax.2 These animals show marked sodium retention and formn large quantities of ascitic fluid. Although this preparationi does not contain a failingo heart, the mechanisms leading to hyperaldosteronism and the changes in salt and water mnetabolism appear to be essentially the same as in experimental right heart failure. The second preparation is the dog with rioht-sided congestive heart failure secondary to progressive pulmonic stenosis.3 This experimental niodel resembles right heart failure in mnan very closely.
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Let us consider first the question " Does aldosterone result in the retention of sodiuni in heart failure?" If so, then bilateral a.drenalectonmy of a dog with experimental ascites should lead to a diuresis in the absence of hormone therapy. The results of an experiment of this type in a dog with thoracic caval constriction are presented in figure 1 . 4 After removal of each of the adrenal glands separately and discontinuation of desoxycorticosterone acetate (DCA), a striking natriuresis occurred. All Kliman and Peterson.8 The high rate of aldosterone secretion by the right adrenal gland in eight dogs with thoracic eaval constriction and in six dogs with experimental right heart failure is compared with aldosterone production in 10 normal dogs ( fig. 3 ).
These findings led to the conclusion that increased production of aldosterone occurs in experimental heart failure.
What about the, other alternative mechanism for hyperaldosteronemia, namely, a decreased rate of metabolism of aldosterone?
Since the liver is, the principal site for metabolism of adrenocortical steroids and the liver is congested in right-sided heart failure, the possibility was considered that aldosterone is inactivated at a subnormal rate. To study this mechanism, H3-d-aldosterone was injected intravenously into normal dogs. and into dogs with chronic hepatic congestion and the rate of disappearanee of the hornmone from peripheral plasma wa.s studied.9 Hepatic congestion resulted in a marked prolongation of the biologieal half-life of H3-d-aldosterone, and the fract-ional turnover rate of the tritiated aldosterone was markedly reduced. Following hepatectomy, the disappearance curves of tritiated aldosterone were almost flat, a finding that reflects the important role of the liver in the metabolism of aldosterone. These results indicate that a decreased rate of metabolism of aldosterone may also contribute to the high blood level of aldosterone in congestive heart failure.
From the combined data on aldosterone seeretion and the turnover rates of the hormone. the peripheral blood level of aldosterone was calculated for normal dogs and for dogs with secondary hyperaldosteronism produced by thoracic eaval constriction. A value of .002 ,ugm./100 ml. of blood was obtained for normal dogs, whereas .090 ttgm./100 ml. of blood was estimated for dogs with experimental secondary hyperaldosteronism. Consequently, the calculations indicate a 45-fold increase in the blood level of aldosterone in dogs with thoracic eaval constriction. The third question is the intriguing one of the meehanisms leading to hypersecretion of aldosterone in heart failure. Evidence10 that the immediate stimulus is hormonal was obtained by cross circulation of blood from a donor dog with thoracic eaval constriction and secondary hyperaldosteronism through The results of a typical experiinent are presented in figure 5 . A striking increase in aldosterone secretion occurred during cross circulation and aldosterone production returned to the control level during the recovery period. The concentration of aldosterone in adrenal vein plasma increased while adrenal blood flow was essentially unehanged. The results of all seven experiments of this type demonstrated an increase in aldosterone secretion in every instance and a return to the control level of aldosterone production in the experiments in which recovery periods were obtained ( fig. 6) The effects of cross circulation of blood from dogs with chronic thoracic caval constriction through normal isola,ted adrenals. figure  9 . Crude kidney extracts were heated to 550 for 10 minutes; the supernatant from these heated extracts showed marked aldosteronestimulating and pressor activity (as indicated by ++++). The supernatant was dialyzed overnight to determine if the active agent is protein. Both the dialysate and butanol extracts of the dialysate failed to produce (see minus sign in figure 9 ) a steroidogenic and a pressor response. In contrast, the nondialyzable protein fraction was highly active. Further fractionation of the protein demonstrated that most of the aldosterone-stimulating activity was in the 1.7 and 2.5 M. ammonium sulfate fractions, which are known to precipitate renin. Also, both fractions increased blood pressure markedly. Heat to 800C. for 10 minutes, which denatures renin,16 destroyed all aldosterone-stimulating and pressor activity, a finding that also suggests that ASH is renin. Finally, assay of the dialysate from unheated crude kidney extracts showed no aldosterone-stimulating activity. Collectively, these results provide strong suggestive evidence that the renal aldosteronestimulating factor is renin.
Before we proceed further, let us review briefly the classical concept of the reninangiotensin system. The kidney secretes the enzyme renin, which acts upon hypertensinogen, an alpha-2 globulin in the blood, to produce angiotensin I, a decapeptide. Angiotensin I is converted by a plasma "converting enzyme" to angiotensin II, which is an octapeptide and the active pressor agent. fleet renin secretion, the most rea.sonable interpretation of the finding is that the rate of renin release by the kidney is augmented in experimental secondary hyperaldosteronism. This result and the interpretation are consistent with the finding of Merrill, Morrison, and Brannon in 194622 that secretion of renin by the kidney is increased in patients with heart failure. If dogs with secondary hyperaldosteronism have a high level of angiotensin II, as the data strongly suggest, the question arises as to the explanation for the absence of hypert.ension in these animals. We reasoned that the blood pressure response to angiotensin II might be less in these animals. To test this hypothesis, a single intravenous injection of synthetic angiotensin II was given to conscious dogs and the blood pressure response Circulation, Volume XXV, June 1962 was measured. The results are presented in the left section of figure 11.15 Synthetic angiotensin II (valine-5-angiotensin II from Ciba) was injected on two occasions into ea,ch of five normal dogs and into five dogs with thoracic eaval constriction and secondary hyperaldosteronism. A log-dose response was obtained in both groups, and the blood pressure response was markedly reduced in the dogs with eaval constriction. A similar reduction in the response to synthetic angiotensin II was observed in another group of five dogs with hyperaldosteronism secondary to chronic so--dium depletion (right section of figure 11 ).
Let us now consider what specific cells in the kidney secrete ASH or renin. Piteock, Hartroft, and Newmark23 and Tobian, Janecek, and Tomboulian24 have provided evidence that renin is secreted by the juxta- 
